Table 1.
All women (n = 199) | Vaginal estrogen (n = 134) | No vaginal estrogen (n = 65) | |
---|---|---|---|
Age | 76.0 (66.0–84.0) | 76.5 (66.0–86.0) | 75.0 (67.0–82.0) |
Body mass index | 25.7 (23.4–28.7) | 25.8 (23.2–28.5) | 25.7 (23.7–30.1) |
Race | |||
White | 187 (94.0) | 128 (95.5) | 59 (90.8) |
Black | 2 (1.0) | 1 (0.7) | 1 (1.5) |
Asian | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Other | 5 (2.5) | 3 (2.2) | 2 (3.1) |
Unknown | 5 (2.5) | 2 (1.5) | 3 (4.6) |
Ethnicity | |||
Hispanic | 2 (1.0) | 0 (0.0) | 2 (3.1) |
Not Hispanic | 192 (96.5) | 132 (98.5) | 60 (92.3) |
Unknown | 5 (2.5) | 2 (1.5) | 3 (4.6) |
Marital status | |||
Single | 11 (5.5) | 9 (6.7) | 2 (3.1) |
Married/partner | 88 (44.2) | 59 (44.0) | 29 (44.6) |
Divorced/separated | 23 (11.6) | 12 (9.0) | 11 (16.9) |
Widowed | 48 (24.1) | 33 (24.6) | 15 (23.1) |
Unknown | 29 (14.6) | 21 (15.7) | 8 (12.3) |
Smoking status | |||
Current smoker | 7 (3.5) | 6 (4.5) | 1 (1.5) |
Former smoker | 61 (30.7) | 41 (30.6) | 20 (30.8) |
Never smoker | 130 (65.3) | 86 (64.2) | 44 (67.7) |
Unknown | 1 (0.5) | 1 (0.7) | 0 (0.0) |
Follow-up (months) | 23.1 (8.7–46.3) | 29.5 (11.0–55.4) | 15.4 (5.5–29.4) |
Diabetes | |||
Yes | 22 (11.1) | 16 (11.9) | 6 (9.2) |
No | 177 (88.9) | 188 (88.1) | 59 (90.8) |
Hysterectomy | |||
Yes | 58 (29.1) | 42 (31.3) | 16 (24.6) |
No | 141 (70.9) | 92 (68.7) | 49 (75.4) |
Bilateral salphingo-oophorectomy | |||
Yes | 28 (14.1) | 22 (16.4) | 6 (9.2) |
No | 171 (85.9) | 112 (83.6) | 59 (90.8) |
Prolapse stage | |||
0 | 5 (2.5) | 3 (2.2) | 2 (3.1) |
1 | 16 (8.0) | 12 (9.0) | 4 (6.2) |
2 | 88 (44.2) | 64 (47.8) | 24 (36.9) |
3 | 73 (36.7) | 45 (33.6) | 28 (43.1) |
4 | 11 (5.5) | 6 (4.5) | 5 (7.7) |
Missing | 6 (3.0) | 4 (3.0) | 2 (3.1) |
Data are presented as median (interquartile range) or n (%)